Caring Contacts Via Text Message for Suicidal Adolescents After Emergency Department Discharge
NCT ID: NCT07043764
Last Updated: 2025-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
56 participants
INTERVENTIONAL
2025-12-31
2028-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All participants will be invited to answer survey questions when they first enroll in the study and 1, 3, 6, and 12 months after their emergency department visit. Some participants will receive Caring Contacts (brief, hopeful, supportive text messages) after their emergency department visit. Some participants will be invited to complete an interview about their experiences receiving Caring Contacts.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual
Treatment as usual consists of a suicide risk assessment during the emergency department visit, determination of disposition, safety planning, provision of crisis resources, and coordination of follow-up mental health services if indicated.
No interventions assigned to this group
Caring Contacts
In addition to Treatment as Usual, participants will receive Caring Contacts, consisting of brief, hopeful, supportive text messages.
Caring Contacts Text Messages
Caring Contacts are brief, hopeful, supportive text messages.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caring Contacts Text Messages
Caring Contacts are brief, hopeful, supportive text messages.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Present to the emergency department with suicidal thoughts or behaviors as indicated by the Ask Suicide-Screening Questions (ASQ)
* Have a cell phone that can receive text messages
* Proficient in English
* Anticipated disposition of discharge from the emergency department
Exclusion Criteria
* Unable to participate meaningfully in assent, assessments, or the intervention, as determined by the treating clinician, including any of the following: acute or chronic cognitive impairment, acute psychosis, current severe agitation, current alcohol or drug intoxication
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Hoffmann
Assistant Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer A. Hoffmann, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jennifer A. Hoffmann, MD, MS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-6680
Identifier Type: -
Identifier Source: org_study_id